首页> 美国卫生研究院文献>other >Gangliosides and Nogo Receptors Independently Mediate Myelin-associated Glycoprotein Inhibition of Neurite Outgrowth in Different Nerve Cells
【2h】

Gangliosides and Nogo Receptors Independently Mediate Myelin-associated Glycoprotein Inhibition of Neurite Outgrowth in Different Nerve Cells

机译:神经节苷脂和Nogo受体独立介导髓鞘相关糖蛋白抑制不同神经细胞中神经突增生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the injured nervous system, myelin-associated glycoprotein (MAG) on residual myelin binds to receptors on axons, inhibits axon outgrowth, and limits functional recovery. Conflicting reports identify gangliosides (GD1a and GT1b) and glycosylphosphatidylinositol-anchored Nogo receptors (NgRs) as exclusive axonal receptors for MAG. We used enzymes and pharmacological agents to distinguish the relative roles of gangliosides and NgRs in MAG-mediated inhibition of neurite outgrowth from three nerve cell types, dorsal root ganglion neurons (DRGNs), cerebellar granule neurons (CGNs), and hippocampal neurons. Primary rat neurons were cultured on control substrata and substrata adsorbed with full-length native MAG extracted from purified myelin. The receptors responsible for MAG inhibition of neurite outgrowth varied with nerve cell type. In DRGNs, most of the MAG inhibition was via NgRs, evidenced by reversal of inhibition by phosphatidylinositol-specific phospholipase C (PI-PLC), which cleaves glycosylphosphatidylinositol anchors, or by NEP1– 40, a peptide inhibitor of NgR. A smaller percentage of MAG inhibition of DRGN outgrowth was via gangliosides, evidenced by partial reversal by addition of sialidase to cleave GD1a and GT1b or by P4, an inhibitor of ganglioside biosynthesis. Combining either PI-PLC and sialidase or NEP1– 40 and P4 was additive. In contrast to DRGNs, in CGNs MAG inhibition was exclusively via gangliosides, whereas inhibition of hippocampal neuron outgrowth was mostly reversed by sialidase or P4 and only modestly reversed by PI-PLC or NEP1– 40 in a non-additive fashion. A soluble proteolytic fragment of native MAG, dMAG, also inhibited neurite outgrowth. In DRGNs, dMAG inhibition was exclusively NgR-dependent, whereas in CGNs it was exclusively ganglioside-dependent. An inhibitor of Rho kinase reversed MAG-mediated inhibition in all nerve cells, whereas a peptide inhibitor of the transducer p75NTR had cell-specific effects quantitatively similar to NgR blockers. Our data indicate that MAG inhibits axon outgrowth via two independent receptors, gangliosides and NgRs.
机译:在受损的神经系统中,残留髓磷脂上的髓磷脂相关糖蛋白(MAG)与轴突上的受体结合,抑制轴突生长并限制功能恢复。相互矛盾的报告指出,神经节苷脂(GD1a和GT1b)和糖基磷脂酰肌醇固定的Nogo受体(NgRs)是MAG的唯一轴突受体。我们使用酶和药理学试剂来区分神经节苷脂和NgR在MAG介导的神经突生长抑制中来自三种神经细胞类型,背根神经节神经元(DRGNs),小脑颗粒神经元(CGNs)和海马神经元的相对作用。将原代大鼠神经元培养在对照基质上,并用从纯化的髓磷脂中提取的全长天然MAG吸附基质。负责MAG抑制神经突生长的受体随神经细胞类型的不同而不同。在DRGNs中,大多数MAG抑制是通过NgR来实现的,这可以通过磷脂酰肌醇特异性磷脂酶C(PI-PLC)的抑制作用逆转来证明,该酶可以切割糖基磷脂酰肌醇锚,或者NEP1-40是NgR的肽抑制剂。通过神经节苷脂,MAG抑制DRGN的生长百分比较小,这可以通过添加唾液酸酶裂解GD1a和GT1b或通过神经节苷脂生物合成抑制剂P4的部分逆转来证明。将PI-PLC和唾液酸酶或NEP1–40和P4组合使用是可加的。与DRGNs相反,在CGNs中,MAG抑制仅通过神经节苷脂来实现,而对海马神经元生长的抑制作用大多被唾液酸酶或P4逆转,而仅由PI-PLC或NEP1–40以非累加的方式适度逆转。天然MAG的可溶性蛋白水解片段dMAG也抑制了神经突的生长。在DRGNs中,dMAG抑制作用完全依赖NgR,而在CGNs中,抑制作用仅取决于神经节苷脂。 Rho激酶抑制剂可逆转所有神经细胞中MAG介导的抑制作用,而p75 NTR 换能器的肽抑制剂具有与NgR阻滞剂定量相似的细胞特异性作用。我们的数据表明,MAG通过两个独立的受体神经节苷脂和NgR抑制轴突生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号